Virology World Conference
Viral Sequencing
Viral Sequencing
Viruses are the most common biological entities on the planet, and they have a huge impact on living beings by producing diseases and influencing their immune systems. Viruses are sequenced in less than 0.01 percent of cases, despite their widespread presence and significance. In terms of etiopathogenesis and the development of innovative therapies, the research of viral infectious diseases is experiencing significant developments at the moment. Virus genome sequencing is an important and fast evolving technology for diagnosing COVID-19 and understanding how the novel coronavirus spreads and is controlled.
- Data Analysis
- Next Generation Sequencing
- Phylogenetics
- Pyrosequencing
- SARS-CoV-2 Sequencing
Committee Members
Oscar Fornas
Pompeu Fabra University and Centre for Genomic Regulation in Barcelona, Spain
Saurabh Chattopadhyay
The University of Toledo, United States
Theodoros Androutsakos
National and Kapodistrian University of Athens, Greece Virology 2022 Speakers
Lucija Nuskern
University of Zagreb, Croatia (Hrvatska)
Pallavi Rai
VA-MD Regional College of Veterinary Medicine, United States
Athanasios-Dimitrios Bakasis
National and Kapodistrian University of Athens, Greece
Ioanna E. Stergiou
National and Kapodistrian University of Athens, Greece
Title : Detection and genetic characterization of emerging viruses in symptomatic children with enteritis
Amoroso Maria Grazia , Zooprofilactic and Experimental Institute of Southern Italy, Italy
Title : Regulation of IRF3 functions to control viral infections
Saurabh Chattopadhyay, The University of Toledo, United States
Title : Post-vaccination antibody responses against SARS-CoV-2 in patients with liver cirrhosis. What do we know so far?
Theodoros Androutsakos, National and Kapodistrian University of Athens, Greece
Title : Single-virus sorting by Flow Cytometry: a methodology to elucidate the virosphere
Oscar Fornas, Pompeu Fabra University and Centre for Genomic Regulation in Barcelona, Spain
Title : Evolutionary trajectory and origin of SARS-CoV-2
Anyou Wang, University of Memphis, United States
Title : Post- vaccination humoral immune responses against SARS-CoV-2 in patients with haematologic malignancies
Ioanna E. Stergiou, National and Kapodistrian University of Athens, Greece